Viral Suppression, Viral Failure, and Safety Outcomes in Children and Adolescents With HIV on Dolutegravir in Europe and Thailand
Karen Scott, John O’Rourke, Charlotte Jackson, Luminita Ene et autres
BACKGROUND: Dolutegravir (DTG) is a preferred anchor antiretroviral therapy (ART) for children and adolescents with HIV (CAWH). METHODS: We assessed the effectiveness and safety of DTG in CAWH aged 0-18 years at DTG start in routine care in Europe and Thailand, evaluating …
gb, ro, il, it, es, de, pl, se, ch, dk, th, gr, ua (code pays fourni par la source)
7 citations
Clinical Infectious Diseases